RK
Schedule 13G filing
Rickel Kenneth disclosed a 7.2% stake in HEPA
Rickel Kenneth reported owning 7.2% of Hepion Pharmaceuticals, Inc. (HEPA) (7,250,000 shares) in a Schedule 13G filed Oct 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 21, 2026
- Source
- Schedule 13G
More HEPA insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.